DANAZOL

DANAZOL was reported 2840 times

DANAZOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 86 0.1874
1 C1 ESTERASE INHIBITOR DECREASED 2 0.1333
2 ENTERITIS NECROTICANS 2 0.0556
3 BONE MARROW RETICULIN FIBROSIS 14 0.0543
4 CORTICAL LAMINAR NECROSIS 2 0.0500
5 VISCERAL VENOUS THROMBOSIS 3 0.0500
6 LYMPHADENITIS 86 0.0355
7 BLOOD STEM CELL TRANSPLANT FAILURE 6 0.0279
8 LIVER IRON CONCENTRATION INCREASED 2 0.0247
9 HEREDITARY ANGIOEDEMA 228 0.0212
10 ACNE FULMINANS 4 0.0204
11 BLOOD ERYTHROPOIETIN INCREASED 2 0.0202
12 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 50 0.0188
13 BOREDOM 6 0.0177
14 BODY HEIGHT ABNORMAL 2 0.0172
15 HAPTOGLOBIN INCREASED 2 0.0146
16 HAEMOLYSIS 101 0.0131
17 BODY HEIGHT INCREASED 6 0.0122
18 BLOOD LACTATE DEHYDROGENASE DECREASED 4 0.0120
19 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE 3 0.0120
20 MYELOFIBROSIS 36 0.0119
21 BLOOD PRODUCT TRANSFUSION DEPENDENT 5 0.0119
22 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA 5 0.0107
23 MIGRAINE WITH AURA 27 0.0099
24 ABDOMINAL INJURY 5 0.0096
25 HYPOPERFUSION 10 0.0095
26 PRIMARY MYELOFIBROSIS 3 0.0093
27 RETICULOCYTE COUNT DECREASED 4 0.0093
28 IRON OVERLOAD 10 0.0093
29 BODY FAT DISORDER 5 0.0092
30 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 6 0.0091
31 BIOPSY BONE MARROW ABNORMAL 4 0.0088
32 RETICULOCYTE COUNT INCREASED 7 0.0087
33 ANGINA BULLOSA HAEMORRHAGICA 2 0.0086
34 SWOLLEN TONGUE 245 0.0078
35 MITRAL VALVE REPLACEMENT 3 0.0076
36 INFUSION SITE THROMBOSIS 2 0.0075
37 VIRAL HAEMORRHAGIC CYSTITIS 5 0.0070
38 ENGRAFT FAILURE 2 0.0070
39 AUTOIMMUNE THROMBOCYTOPENIA 3 0.0069
40 MUCOSAL HAEMORRHAGE 8 0.0069
41 CUSHINGOID 22 0.0068
42 MALIGNANT TRANSFORMATION 3 0.0067
43 CENTRAL VENOUS CATHETER REMOVAL 3 0.0064
44 IDIOPATHIC THROMBOCYTOPENIC PURPURA 10 0.0063
45 ANGIOEDEMA 264 0.0060
46 MARROW HYPERPLASIA 4 0.0059
47 TRANSFUSION REACTION 5 0.0057
48 FAT EMBOLISM 2 0.0056
49 STRESS URINARY INCONTINENCE 6 0.0056
50 LISTERIOSIS 6 0.0054
51 HAEMOGLOBINURIA 6 0.0054
52 BLOOD IRON INCREASED 10 0.0053
53 PULMONARY ARTERY THROMBOSIS 4 0.0052
54 SPLENECTOMY 6 0.0052
55 IMMUNE THROMBOCYTOPENIA 22 0.0048
56 DISCOURAGEMENT 11 0.0047
57 BODY HEIGHT BELOW NORMAL 3 0.0047
58 ANISOCYTOSIS 3 0.0046
59 CHRONIC MYELOMONOCYTIC LEUKAEMIA 3 0.0045
60 HAEMOCHROMATOSIS 4 0.0043
61 PLATELET COUNT ABNORMAL 26 0.0043
62 DYSPHONIA 249 0.0043
63 RED BLOOD CELL ABNORMALITY 4 0.0042
64 BLAST CELLS PRESENT 2 0.0042
65 IMMUNODEFICIENCY COMMON VARIABLE 2 0.0041
66 EVANS SYNDROME 2 0.0041
67 FOCAL NODULAR HYPERPLASIA 2 0.0038
68 SWELLING FACE 250 0.0038
69 CRYPTOSPORIDIOSIS INFECTION 2 0.0038
70 ABDOMINAL SYMPTOM 3 0.0037
71 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 203 0.0037
72 HYPERTROPHY 2 0.0037
73 INTRAVASCULAR HAEMOLYSIS 2 0.0036
74 CEREBRAL VENOUS THROMBOSIS 6 0.0033
75 VASOSPASM 3 0.0033
76 HAEMATOCRIT ABNORMAL 4 0.0033
77 CEREBRAL ASPERGILLOSIS 2 0.0033
78 APLASTIC ANAEMIA 17 0.0033
79 SPLENOMEGALY 37 0.0032
80 LIP HAEMORRHAGE 4 0.0031
81 MEAN CELL VOLUME INCREASED 8 0.0031
82 BLAST CELL COUNT INCREASED 3 0.0029
83 SERUM FERRITIN INCREASED 15 0.0028
84 INFUSION SITE BRUISING 6 0.0028
85 ECCHYMOSIS 19 0.0028
86 MYELODYSPLASTIC SYNDROME 40 0.0028
87 BACTERIAL DISEASE CARRIER 2 0.0027
88 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 2 0.0027
89 BLISTER RUPTURE 2 0.0027
90 PLATELET COUNT INCREASED 35 0.0027
91 DRUG INTOLERANCE 252 0.0026
92 MYELITIS 4 0.0026
93 EROSIVE DUODENITIS 2 0.0025
94 ANTIPHOSPHOLIPID SYNDROME 4 0.0025
95 ACUTE LEUKAEMIA 4 0.0025
96 IMMUNE THROMBOCYTOPENIC PURPURA 7 0.0025
97 THROMBOCYTOSIS 9 0.0025
98 JUVENILE IDIOPATHIC ARTHRITIS 6 0.0025
99 ALLERGY TO CHEMICALS 3 0.0024
100 INCISION SITE COMPLICATION 2 0.0024
101 PLATELET DISORDER 6 0.0024
102 ADNEXA UTERI PAIN 3 0.0023
103 LIP INJURY 3 0.0023
104 INTRACARDIAC THROMBUS 7 0.0023
105 PNEUMOCYSTIS JIROVECI PNEUMONIA 5 0.0022
106 ANION GAP INCREASED 3 0.0022
107 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0022
108 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0022
109 HAEMATOLOGICAL MALIGNANCY 6 0.0021
110 BILIARY COLIC 6 0.0021
111 NORMOCYTIC ANAEMIA 3 0.0020
112 HAEMOPHILUS INFECTION 2 0.0020
113 CYTOMEGALOVIRUS INFECTION REACTIVATION 9 0.0020
114 PNEUMONIA FUNGAL 8 0.0020
115 PETECHIAE 21 0.0020
116 BONE MARROW DISORDER 6 0.0020
117 GINGIVAL BLEEDING 27 0.0020
118 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 3 0.0020
119 BLOOD CHLORIDE DECREASED 5 0.0019
120 ATRIAL THROMBOSIS 4 0.0019
121 IRIDOCYCLITIS 6 0.0019
122 EYE CONTUSION 4 0.0019
123 ALCOHOL POISONING 5 0.0019
124 JOINT CONTRACTURE 2 0.0019
125 BONE NEOPLASM 2 0.0019
126 AUTOIMMUNE THYROIDITIS 7 0.0018
127 PLATELET COUNT DECREASED 196 0.0018
128 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 3 0.0018
129 LARYNGEAL OEDEMA 11 0.0018
130 CATHETER SITE DISCHARGE 2 0.0018
131 BK VIRUS INFECTION 6 0.0018
132 AUTOIMMUNE HAEMOLYTIC ANAEMIA 6 0.0017
133 APLASIA PURE RED CELL 6 0.0017
134 BLOOD LACTATE DEHYDROGENASE INCREASED 27 0.0017
135 THERAPEUTIC PRODUCT EFFECT DECREASED 76 0.0017
136 CHRONIC LYMPHOCYTIC LEUKAEMIA 8 0.0017
137 JUGULAR VEIN THROMBOSIS 3 0.0017
138 FIBROSIS 5 0.0016
139 HEPATIC ENZYME INCREASED 110 0.0016
140 HEPATOCELLULAR CARCINOMA 12 0.0016
141 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 27 0.0016
142 NOCARDIOSIS 4 0.0016
143 BODY HEIGHT DECREASED 16 0.0015
144 INFUSION RELATED REACTION 98 0.0015
145 ORAL FUNGAL INFECTION 4 0.0015
146 ABSCESS ORAL 2 0.0015
147 SKIN INDURATION 3 0.0014
148 HAEMOGLOBIN DECREASED 147 0.0014
149 URINARY BLADDER HAEMORRHAGE 3 0.0014
150 HEPATOMEGALY 14 0.0014
151 HYPERSENSITIVITY 263 0.0014
152 CONNECTIVE TISSUE DISORDER 2 0.0014
153 HAEMORRHAGIC DIATHESIS 5 0.0014
154 RHABDOMYOLYSIS 58 0.0014
155 FAT TISSUE INCREASED 2 0.0014
156 WALKING AID USER 9 0.0014
157 DIABETIC NEPHROPATHY 3 0.0014
158 PURPURA 12 0.0014
159 CHOLESTATIC LIVER INJURY 3 0.0013
160 BACTERIAL TEST POSITIVE 3 0.0013
161 GASTRITIS HAEMORRHAGIC 2 0.0013
162 GINGIVAL HYPERTROPHY 2 0.0013
163 LUMBAR VERTEBRAL FRACTURE 6 0.0013
164 DIABETIC FOOT 4 0.0013
165 DUODENITIS 4 0.0013
166 ACUTE MYELOID LEUKAEMIA 20 0.0013
167 HAND FRACTURE 9 0.0013
168 INFUSION SITE PRURITUS 4 0.0013
169 MOUTH HAEMORRHAGE 9 0.0012
170 INTESTINAL POLYP 2 0.0012
171 SUSPECTED COVID-19 4 0.0012
172 GASTRIC DILATATION 2 0.0012
173 CATHETER SITE HAEMORRHAGE 3 0.0012
174 URINARY TRACT INFECTION BACTERIAL 3 0.0012
175 LEUKAEMIA RECURRENT 2 0.0012
176 HEPATOSPLENOMEGALY 3 0.0012
177 ACUTE SINUSITIS 2 0.0012
178 PERIORBITAL OEDEMA 6 0.0012
179 BREAST DISCHARGE 2 0.0011
180 BURNS SECOND DEGREE 2 0.0011
181 FIBRIN D DIMER INCREASED 4 0.0011
182 WHITE BLOOD CELL DISORDER 3 0.0011
183 BUNDLE BRANCH BLOCK RIGHT 5 0.0011
184 BONE MARROW FAILURE 22 0.0011
185 THROMBOCYTOPENIA 121 0.0011
186 DENTAL CARE 2 0.0011
187 NEPHROPATHY TOXIC 12 0.0011
188 SKIN HYPERTROPHY 3 0.0011
189 TRANSFUSION 11 0.0010
190 HYPOVOLAEMIC SHOCK 5 0.0010
191 MYOPATHY 9 0.0010
192 ATROPHY 2 0.0010
193 EARLY SATIETY 2 0.0010
194 CONCOMITANT DISEASE PROGRESSION 2 0.0010
195 ACUTE MYOCARDIAL INFARCTION 30 0.0010
196 CREPITATIONS 3 0.0010
197 NORMOCHROMIC NORMOCYTIC ANAEMIA 3 0.0010
198 PAPULE 7 0.0010
199 NEPHROGENIC SYSTEMIC FIBROSIS 3 0.0010
200 FUNGAL SKIN INFECTION 4 0.0010
201 BLOOD COUNT ABNORMAL 15 0.0010
202 EAR HAEMORRHAGE 2 0.0010
203 MIGRAINE 94 0.0010
204 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 4 0.0010
205 PORTAL HYPERTENSION 3 0.0010
206 PRODUCT DISTRIBUTION ISSUE 9 0.0010
207 BENIGN PROSTATIC HYPERPLASIA 5 0.0010
208 RED CELL DISTRIBUTION WIDTH INCREASED 4 0.0010
209 CONGESTIVE CARDIOMYOPATHY 4 0.0010
210 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 9 0.0009
211 CARDIAC FAILURE CHRONIC 4 0.0009
212 PSEUDOMONAS INFECTION 8 0.0009
213 HAEMOGLOBIN ABNORMAL 6 0.0009
214 HORDEOLUM 4 0.0009
215 DIVERTICULUM INTESTINAL 4 0.0009
216 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 2 0.0009
217 ACCIDENT AT WORK 2 0.0009
218 HYPERCALCAEMIA 11 0.0009
219 IRON DEFICIENCY 4 0.0009
220 GASTRIC POLYPS 2 0.0009
221 PERIORBITAL SWELLING 5 0.0009
222 HAEMATOCRIT INCREASED 2 0.0009
223 INTERNATIONAL NORMALISED RATIO ABNORMAL 3 0.0009
224 DIFFICULTY IN WALKING 3 0.0009
225 VIITH NERVE PARALYSIS 3 0.0009
226 THERAPY NON-RESPONDER 39 0.0009
227 AUTOIMMUNE HEPATITIS 6 0.0009
228 AORTIC STENOSIS 3 0.0009
229 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 2 0.0009
230 MULTIPLE MYELOMA 4 0.0009
231 FEELING OF DESPAIR 4 0.0009
232 THROMBOPHLEBITIS 3 0.0009
233 DEPRESSIVE SYMPTOM 3 0.0009
234 MULTIPLE ORGAN DYSFUNCTION SYNDROME 24 0.0008
235 SKIN ABRASION 4 0.0008
236 FULL BLOOD COUNT DECREASED 17 0.0008
237 SECOND PRIMARY MALIGNANCY 7 0.0008
238 INTRA-ABDOMINAL HAEMORRHAGE 2 0.0008
239 PRODUCT AVAILABILITY ISSUE 19 0.0008
240 APPARENT DEATH 3 0.0008
241 BREATH ODOUR 2 0.0008
242 CONCOMITANT DISEASE AGGRAVATED 5 0.0008
243 WHITE BLOOD CELL COUNT INCREASED 31 0.0008
244 ANEURYSM 4 0.0008
245 CHROMATURIA 18 0.0008
246 PROTEIN TOTAL DECREASED 3 0.0008
247 DERMATITIS ALLERGIC 10 0.0008
248 EXPOSURE VIA INGESTION 2 0.0008
249 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 4 0.0008
250 INSURANCE ISSUE 12 0.0008
251 WHITE BLOOD CELL COUNT ABNORMAL 5 0.0008
252 CACHEXIA 4 0.0008
253 INCREASED TENDENCY TO BRUISE 7 0.0008
254 THERAPEUTIC RESPONSE DECREASED 46 0.0008
255 NEUTROPENIA 103 0.0008
256 SKIN PAPILLOMA 3 0.0007
257 ABDOMINAL MASS 2 0.0007
258 CYSTITIS HAEMORRHAGIC 3 0.0007
259 GASTROINTESTINAL INJURY 2 0.0007
260 ABDOMINAL RIGIDITY 2 0.0007
261 LIMB INJURY 20 0.0007
262 CARDIOMEGALY 9 0.0007
263 EMBOLISM 6 0.0007
264 THYROID FUNCTION TEST ABNORMAL 3 0.0007
265 LEUKOCYTOSIS 13 0.0007
266 CONTUSION 69 0.0007
267 MASS 10 0.0007
268 PHARYNGEAL SWELLING 7 0.0007
269 DECREASED IMMUNE RESPONSIVENESS 7 0.0007
270 INFUSION SITE ERYTHEMA 6 0.0007
271 HAEMATOCRIT DECREASED 14 0.0007
272 LEFT VENTRICULAR HYPERTROPHY 3 0.0007
273 RED BLOOD CELL COUNT DECREASED 20 0.0007
274 DUODENAL ULCER HAEMORRHAGE 2 0.0007
275 INFUSION SITE PAIN 9 0.0007
276 GRAFT VERSUS HOST DISEASE 5 0.0007
277 OCULAR ICTERUS 3 0.0007
278 RASH PUSTULAR 5 0.0007
279 HYPOVOLAEMIA 4 0.0007
280 CYTOMEGALOVIRUS VIRAEMIA 3 0.0007
281 HEPATITIS FULMINANT 2 0.0007
282 QUALITY OF LIFE DECREASED 9 0.0007
283 CENTRAL VENOUS CATHETERISATION 2 0.0007
284 CYTOMEGALOVIRUS INFECTION 11 0.0007
285 PNEUMONIA BACTERIAL 6 0.0007
286 CYTOPENIA 8 0.0007
287 ISCHAEMIC CARDIOMYOPATHY 2 0.0007
288 GRAND MAL CONVULSION 6 0.0006
289 DECREASED ACTIVITY 7 0.0006
290 RENAL FUNCTION TEST ABNORMAL 3 0.0006
291 GASTRITIS 17 0.0006
292 SKIN LACERATION 7 0.0006
293 YELLOW SKIN 3 0.0006
294 EPSTEIN-BARR VIRUS INFECTION 4 0.0006
295 BLOOD BLISTER 2 0.0006
296 BLOOD CREATININE DECREASED 2 0.0006
297 MULTIPLE ALLERGIES 5 0.0006
298 RENAL FAILURE ACUTE 27 0.0006
299 INFUSION SITE SWELLING 4 0.0006
300 FOREIGN BODY IN THROAT 2 0.0006
301 PRODUCT USE IN UNAPPROVED INDICATION 156 0.0006
302 SUBCUTANEOUS ABSCESS 3 0.0006
303 SENSORY LOSS 5 0.0006
304 EPISTAXIS 46 0.0006
305 RENAL CELL CARCINOMA 3 0.0006
306 HYPOGAMMAGLOBULINAEMIA 4 0.0006
307 JOINT INJURY 13 0.0006
308 BLADDER DISORDER 6 0.0006
309 BLOOD PRESSURE ABNORMAL 12 0.0006
310 VASCULITIS 7 0.0006
311 HAEMODIALYSIS 5 0.0006
312 ANAEMIA 113 0.0006
313 POSTOPERATIVE WOUND INFECTION 4 0.0006
314 CONSTIPATION 129 0.0006
315 ULCER HAEMORRHAGE 4 0.0006
316 DYSLIPIDAEMIA 3 0.0006
317 DRY THROAT 6 0.0006
318 B-CELL LYMPHOMA 2 0.0006
319 PALLOR 16 0.0006
320 LIVER DISORDER 26 0.0006
321 PHLEBITIS 3 0.0006
322 DEVICE RELATED INFECTION 9 0.0006
323 EAR DISCOMFORT 6 0.0006
324 SEPSIS 65 0.0006
325 PERIPHERAL VASCULAR DISORDER 3 0.0006
326 HYPERBILIRUBINAEMIA 6 0.0006
327 THERAPY PARTIAL RESPONDER 9 0.0006
328 TONSILLITIS 3 0.0006
329 HEADACHE 358 0.0006
330 HANGOVER 2 0.0006
331 LYMPHOPENIA 8 0.0006
332 HEART DISEASE CONGENITAL 2 0.0006
333 JAUNDICE 15 0.0006
334 GOUT 10 0.0006
335 GINGIVITIS 3 0.0006
336 FACIAL BONES FRACTURE 2 0.0006
337 BLOOD BILIRUBIN INCREASED 15 0.0006
338 CHRONIC GRAFT VERSUS HOST DISEASE 2 0.0006
339 PSYCHIATRIC SYMPTOM 4 0.0005
340 HYPOPHOSPHATAEMIA 4 0.0005
341 HAEMATOMA 14 0.0005
342 HEPATOTOXICITY 12 0.0005
343 CARDIAC DYSFUNCTION 2 0.0005
344 INTERMENSTRUAL BLEEDING 3 0.0005
345 HAEMORRHAGE INTRACRANIAL 8 0.0005
346 CHRONIC SINUSITIS 2 0.0005
347 EYE INFECTION 6 0.0005
348 CATHETER SITE INFECTION 2 0.0005
349 OFF LABEL USE 463 0.0005
350 FACE INJURY 2 0.0005
351 GRANULOCYTOPENIA 3 0.0005
352 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
353 NEPHROLITHIASIS 24 0.0005
354 SKIN ATROPHY 3 0.0005
355 HYPERCHOLESTEROLAEMIA 5 0.0005
356 ATELECTASIS 5 0.0005
357 EATING DISORDER 11 0.0005
358 UVEITIS 7 0.0005
359 BRONCHOPULMONARY ASPERGILLOSIS 4 0.0005
360 LIVER FUNCTION TEST ABNORMAL 15 0.0005
361 POST PROCEDURAL HAEMORRHAGE 6 0.0005
362 EPIGASTRIC DISCOMFORT 2 0.0005
363 THERAPY CHANGE 5 0.0005
364 COVID-19 PNEUMONIA 6 0.0005
365 BLOOD CREATININE INCREASED 33 0.0005
366 ODYNOPHAGIA 3 0.0005
367 HYPERLIPIDAEMIA 6 0.0005
368 OVARIAN CYST 5 0.0005
369 CANDIDIASIS 2 0.0005
370 INTRACRANIAL ANEURYSM 2 0.0005
371 HEPATITIS B 3 0.0005
372 SKIN REACTION 7 0.0005
373 SEASONAL ALLERGY 7 0.0005
374 INTERNATIONAL NORMALISED RATIO DECREASED 2 0.0005
375 BLOOD POTASSIUM INCREASED 8 0.0005
376 NO THERAPEUTIC RESPONSE 6 0.0005
377 ASPHYXIA 4 0.0005
378 HYPERURICAEMIA 2 0.0005
379 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 4 0.0005
380 BLOOD UREA INCREASED 8 0.0005
381 ABSCESS LIMB 2 0.0005
382 INTENTIONAL PRODUCT USE ISSUE 41 0.0005
383 HYPERGLYCAEMIA 17 0.0005
384 MUSCULOSKELETAL DISCOMFORT 8 0.0005
385 HEPATIC LESION 2 0.0005
386 DISEASE RECURRENCE 22 0.0005
387 OEDEMA 25 0.0005
388 PULMONARY THROMBOSIS 5 0.0005
389 CHOLELITHIASIS 15 0.0005
390 HYPERKALAEMIA 16 0.0005
391 ALANINE AMINOTRANSFERASE INCREASED 28 0.0005
392 UPPER RESPIRATORY TRACT INFECTION 21 0.0005
393 DEPRESSED MOOD 24 0.0005
394 IMMUNOSUPPRESSION 4 0.0005
395 GINGIVAL SWELLING 2 0.0005
396 EXPIRED PRODUCT ADMINISTERED 15 0.0005
397 HAEMORRHAGE 47 0.0004
398 PREGNANCY 9 0.0004
399 DRUG INTERACTION 71 0.0004
400 HAEMOLYTIC ANAEMIA 4 0.0004
401 GASTROINTESTINAL INFECTION 4 0.0004
402 COLITIS ISCHAEMIC 3 0.0004
403 BLOOD CALCIUM DECREASED 5 0.0004
404 BLOOD ALKALINE PHOSPHATASE INCREASED 11 0.0004
405 HEAD INJURY 14 0.0004
406 OBESITY 7 0.0004
407 HAEMOGLOBIN INCREASED 2 0.0004
408 WHITE BLOOD CELL COUNT DECREASED 47 0.0004
409 CHRONIC MYELOID LEUKAEMIA 2 0.0004
410 PERICARDIAL EFFUSION 10 0.0004
411 LOCALISED OEDEMA 2 0.0004
412 NEOPLASM PROGRESSION 15 0.0004
413 GASTROINTESTINAL HAEMORRHAGE 36 0.0004
414 GASTRITIS EROSIVE 2 0.0004
415 RENAL IMPAIRMENT 36 0.0004
416 APPENDICITIS 4 0.0004
417 INFLUENZA 47 0.0004
418 BLOOD URINE PRESENT 8 0.0004
419 BLOOD IRON DECREASED 5 0.0004
420 BACTERAEMIA 5 0.0004
421 VIRAL INFECTION 14 0.0004
422 PRODUCT SUPPLY ISSUE 3 0.0004
423 COAGULOPATHY 7 0.0004
424 NEUTROPENIC SEPSIS 3 0.0004
425 ENDOMETRIOSIS 2 0.0004
426 MYOCLONUS 5 0.0004
427 FAECAL INCONTINENCE 2 0.0004
428 PANCREATITIS 22 0.0004
429 PANCYTOPENIA 23 0.0004
430 PRESYNCOPE 10 0.0004
431 AUTOIMMUNE DISORDER 4 0.0004
432 BONE PAIN 24 0.0004
433 BREATH SOUNDS ABNORMAL 2 0.0004
434 HOSPICE CARE 4 0.0004
435 ARTHROPOD BITE 3 0.0004
436 LIGAMENT SPRAIN 4 0.0004
437 NIGHT SWEATS 13 0.0004
438 APPLICATION SITE SWELLING 2 0.0004
439 HEPATIC ENZYME ABNORMAL 2 0.0004
440 DYSPNOEA EXERTIONAL 15 0.0004
441 EMPHYSEMA 4 0.0004
442 BRAIN OEDEMA 5 0.0004
443 KLEBSIELLA INFECTION 2 0.0004
444 TROPONIN INCREASED 3 0.0004
445 AMMONIA INCREASED 2 0.0004
446 BOWEL MOVEMENT IRREGULARITY 3 0.0004
447 LIPASE INCREASED 3 0.0004
448 NEUTROPHIL COUNT INCREASED 4 0.0004
449 RENAL FAILURE CHRONIC 3 0.0004
450 CONCUSSION 3 0.0004
451 TOOTHACHE 7 0.0004
452 POOR VENOUS ACCESS 4 0.0004
453 HYPOALBUMINAEMIA 3 0.0004
454 END STAGE RENAL DISEASE 7 0.0004
455 WEIGHT FLUCTUATION 4 0.0004
456 TOOTH INFECTION 5 0.0004
457 FULL BLOOD COUNT ABNORMAL 4 0.0004
458 BLOOD ALBUMIN DECREASED 3 0.0004
459 RENAL CYST 3 0.0004
460 GINGIVAL PAIN 3 0.0004
461 ATRIAL FLUTTER 3 0.0004
462 HEPATIC STEATOSIS 7 0.0004
463 BACTERIAL INFECTION 7 0.0004
464 FEAR 10 0.0004
465 RENAL FAILURE 49 0.0004
466 FAECES DISCOLOURED 8 0.0004
467 SHOCK HAEMORRHAGIC 3 0.0004
468 PROTEINURIA 7 0.0004
469 NEUTROPHIL COUNT DECREASED 15 0.0004
470 HYDROCEPHALUS 2 0.0004
471 OESOPHAGITIS 4 0.0004
472 WOUND INFECTION 4 0.0004
473 HEPATIC FAILURE 11 0.0004
474 RENAL DISORDER 17 0.0004
475 INTESTINAL ISCHAEMIA 2 0.0004
476 SPINAL COMPRESSION FRACTURE 3 0.0004
477 DRUG INEFFECTIVE 478 0.0004
478 HYPERKERATOSIS 2 0.0004
479 HERNIA 7 0.0004
480 DENTAL CARIES 4 0.0004
481 HEMIPLEGIA 3 0.0004
482 TRANSAMINASES INCREASED 8 0.0004
483 NERVE INJURY 4 0.0004
484 ASPARTATE AMINOTRANSFERASE INCREASED 19 0.0004
485 ANGIOPATHY 2 0.0004
486 PANCREATITIS ACUTE 8 0.0004
487 INTERNATIONAL NORMALISED RATIO INCREASED 10 0.0004
488 CARDIAC VALVE DISEASE 2 0.0003
489 SUBDURAL HAEMATOMA 5 0.0003
490 CORONARY ARTERY BYPASS 2 0.0003
491 GASTRIC HAEMORRHAGE 4 0.0003
492 PSYCHOLOGICAL TRAUMA 3 0.0003
493 EXERCISE TOLERANCE DECREASED 2 0.0003
494 TREATMENT NONCOMPLIANCE 19 0.0003
495 HERPES VIRUS INFECTION 2 0.0003
496 CARDIAC MURMUR 3 0.0003
497 ENTEROCOLITIS 2 0.0003
498 URINE OUTPUT DECREASED 3 0.0003
499 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3 0.0003
500 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
501 DECREASED INTEREST 2 0.0003
502 TREATMENT FAILURE 28 0.0003
503 GENERAL PHYSICAL HEALTH DETERIORATION 39 0.0003
504 IMMUNODEFICIENCY 5 0.0003
505 CEREBRAL HAEMORRHAGE 12 0.0003
506 ACCIDENT 4 0.0003
507 ROAD TRAFFIC ACCIDENT 14 0.0003
508 RESPIRATORY DISORDER 10 0.0003
509 FLUID RETENTION 17 0.0003
510 MOBILITY DECREASED 24 0.0003
511 HEPATITIS CHOLESTATIC 2 0.0003
512 CRYING 12 0.0003
513 TOXIC EPIDERMAL NECROLYSIS 5 0.0003
514 FIBROMYALGIA 8 0.0003
515 INGUINAL HERNIA 2 0.0003
516 ASTHENIA 123 0.0003
517 ANAPHYLACTIC REACTION 18 0.0003
518 SKIN CANCER 7 0.0003
519 NERVE COMPRESSION 3 0.0003
520 PHARYNGEAL OEDEMA 5 0.0003
521 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
522 LYMPHOMA 5 0.0003
523 DEEP VEIN THROMBOSIS 21 0.0003
524 MUSCULOSKELETAL CHEST PAIN 5 0.0003
525 PHARYNGITIS 4 0.0003
526 ERYTHEMA MULTIFORME 3 0.0003
527 FLANK PAIN 3 0.0003
528 ARTERIOSCLEROSIS 3 0.0003
529 DRUG-INDUCED LIVER INJURY 10 0.0003
530 ATRIAL FIBRILLATION 31 0.0003
531 LEUKAEMIA 3 0.0003
532 CELLULITIS 16 0.0003
533 FOOT FRACTURE 6 0.0003
534 SLEEP APNOEA SYNDROME 6 0.0003
535 HYPERSOMNIA 9 0.0003
536 HEPATITIS 8 0.0003
537 ENTERITIS 2 0.0003
538 HAEMATOCHEZIA 17 0.0003
539 HERPES SIMPLEX 2 0.0003
540 LUNG DISORDER 15 0.0003
541 RENAL TUBULAR NECROSIS 3 0.0003
542 LABORATORY TEST ABNORMAL 9 0.0003
543 BEDRIDDEN 4 0.0003
544 IMMUNE SYSTEM DISORDER 4 0.0003
545 EAR INFECTION 8 0.0003
546 EYE HAEMORRHAGE 4 0.0003
547 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
548 BREAST MASS 2 0.0003
549 FEEDING DISORDER 6 0.0003
550 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 21 0.0003
551 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
552 TOOTH ABSCESS 3 0.0003
553 PRODUCT PRESCRIBING ERROR 7 0.0003
554 ACUTE HEPATIC FAILURE 4 0.0003
555 SCAR 5 0.0003
556 HELICOBACTER INFECTION 3 0.0003
557 SKIN LESION 8 0.0003
558 WEIGHT INCREASED 65 0.0003
559 JOINT EFFUSION 2 0.0003
560 LOCALISED INFECTION 7 0.0003
561 HAIR GROWTH ABNORMAL 2 0.0003
562 TENDERNESS 3 0.0003
563 ABDOMINAL DISTENSION 30 0.0003
564 PNEUMONIA 93 0.0003
565 HAEMOPTYSIS 8 0.0003
566 BLOOD TEST ABNORMAL 4 0.0003
567 SCRATCH 3 0.0003
568 DISSEMINATED INTRAVASCULAR COAGULATION 4 0.0003
569 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
570 SKIN DISCOLOURATION 13 0.0003
571 COVID-19 49 0.0003
572 PRODUCT USE ISSUE 52 0.0003
573 ASPIRATION 3 0.0003
574 LOSS OF CONSCIOUSNESS 35 0.0003
575 WEIGHT DECREASED 76 0.0003
576 TOOTH FRACTURE 3 0.0003
577 BLINDNESS TRANSIENT 2 0.0003
578 CARDIOMYOPATHY 4 0.0003
579 URINARY INCONTINENCE 8 0.0003
580 RESPIRATORY TRACT INFECTION 7 0.0003
581 NERVOUSNESS 14 0.0003
582 HEPATIC FUNCTION ABNORMAL 10 0.0003
583 INTESTINAL PERFORATION 3 0.0003
584 BLOOD SODIUM DECREASED 5 0.0003
585 MITRAL VALVE INCOMPETENCE 3 0.0003
586 CORONARY ARTERY DISEASE 8 0.0003
587 CHOLECYSTECTOMY 3 0.0003
588 INTERNAL HAEMORRHAGE 3 0.0003
589 HAEMODYNAMIC INSTABILITY 2 0.0003
590 MYOCARDITIS 3 0.0003
591 FOOD ALLERGY 2 0.0003
592 PRESCRIBED OVERDOSE 5 0.0003
593 CONGENITAL ANOMALY 2 0.0003
594 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
595 TENDONITIS 4 0.0003
596 ELECTROLYTE IMBALANCE 3 0.0003
597 EJECTION FRACTION DECREASED 4 0.0003
598 BASAL CELL CARCINOMA 4 0.0003
599 NERVOUS SYSTEM DISORDER 8 0.0003
600 INJURY 18 0.0003
601 GASTROINTESTINAL INFLAMMATION 2 0.0003
602 MENORRHAGIA 5 0.0003
603 AFFECTIVE DISORDER 2 0.0003
604 CYANOSIS 4 0.0003
605 PULMONARY EMBOLISM 24 0.0003
606 MENTAL STATUS CHANGES 7 0.0003
607 GAIT DISTURBANCE 48 0.0003
608 POLYNEUROPATHY 3 0.0003
609 HYPOTHYROIDISM 8 0.0003
610 BLOOD PRESSURE FLUCTUATION 6 0.0002
611 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 45 0.0002
612 FRUSTRATION TOLERANCE DECREASED 2 0.0002
613 RESPIRATORY FAILURE 18 0.0002
614 PERIPHERAL SWELLING 38 0.0002
615 DECUBITUS ULCER 2 0.0002
616 BACK PAIN 57 0.0002
617 DISEASE PROGRESSION 29 0.0002
618 BRONCHITIS 18 0.0002
619 ILLNESS 25 0.0002
620 ILEUS 3 0.0002
621 FATIGUE 186 0.0002
622 NASAL CONGESTION 14 0.0002
623 OEDEMA PERIPHERAL 29 0.0002
624 TYPE 2 DIABETES MELLITUS 8 0.0002
625 FALL 79 0.0002
626 FACE OEDEMA 4 0.0002
627 HAEMATEMESIS 6 0.0002
628 HYPERTENSION 50 0.0002
629 GASTROOESOPHAGEAL REFLUX DISEASE 19 0.0002
630 INFECTION 34 0.0002
631 SINUSITIS 24 0.0002
632 HAEMATURIA 8 0.0002
633 IRRITABLE BOWEL SYNDROME 5 0.0002
634 BALANCE DISORDER 20 0.0002
635 CONTRAINDICATED PRODUCT ADMINISTERED 7 0.0002
636 AMNESIA 15 0.0002
637 ILL-DEFINED DISORDER 14 0.0002
638 VAGINAL HAEMORRHAGE 10 0.0002
639 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 12 0.0002
640 PRODUCT PRESCRIBING ISSUE 5 0.0002
641 LOCAL SWELLING 4 0.0002
642 BLOOD PRESSURE INCREASED 35 0.0002
643 AMENORRHOEA 4 0.0002
644 ABDOMINAL PAIN 53 0.0002
645 PULMONARY CONGESTION 3 0.0002
646 COLD SWEAT 4 0.0002
647 OROPHARYNGEAL PAIN 21 0.0002
648 NAUSEA 179 0.0002
649 BLOOD PRESSURE DECREASED 15 0.0002
650 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
651 FACIAL PAIN 2 0.0002
652 THIRST 4 0.0002
653 JOINT SWELLING 27 0.0002
654 ORAL PAIN 5 0.0002
655 HEAVY MENSTRUAL BLEEDING 2 0.0002
656 MALAISE 97 0.0002
657 TACHYPNOEA 3 0.0002
658 CYSTITIS 7 0.0002
659 CATARACT 13 0.0002
660 PROCEDURAL PAIN 6 0.0002
661 CHEST PAIN 40 0.0002
662 ARTHROPATHY 12 0.0002
663 AGRANULOCYTOSIS 4 0.0002
664 WOUND 6 0.0002
665 PLEURAL EFFUSION 13 0.0002
666 HEPATIC CIRRHOSIS 4 0.0002
667 LACERATION 2 0.0002
668 INTESTINAL OBSTRUCTION 8 0.0002
669 HEPATOCELLULAR INJURY 3 0.0002
670 CHRONIC KIDNEY DISEASE 16 0.0002
671 HAEMATOTOXICITY 2 0.0002
672 PAIN IN EXTREMITY 62 0.0002
673 DIABETES MELLITUS 16 0.0002
674 SYNCOPE 21 0.0002
675 HERPES ZOSTER 12 0.0002
676 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
677 ACUTE RESPIRATORY FAILURE 4 0.0002
678 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
679 HYPERTHYROIDISM 3 0.0002
680 SEPTIC SHOCK 9 0.0002
681 FLUID OVERLOAD 3 0.0002
682 EAR PAIN 4 0.0002
683 NEURALGIA 5 0.0002
684 DYSSTASIA 6 0.0002
685 URINARY TRACT INFECTION 35 0.0002
686 HAEMORRHOIDS 4 0.0002
687 LIVER INJURY 5 0.0002
688 KNEE OPERATION 2 0.0002
689 BODY TEMPERATURE DECREASED 2 0.0002
690 PYREXIA 70 0.0002
691 INABILITY TO AFFORD MEDICATION 2 0.0002
692 COLON CANCER 3 0.0002
693 UPPER LIMB FRACTURE 4 0.0002
694 BLOOD POTASSIUM DECREASED 6 0.0002
695 THROMBOSIS 16 0.0002
696 ECONOMIC PROBLEM 3 0.0002
697 DRUG DISPENSING ERROR 3 0.0002
698 FEBRILE NEUTROPENIA 13 0.0002
699 BLISTER 11 0.0002
700 DRUG ADMINISTRATION ERROR 6 0.0002
701 ELECTROCARDIOGRAM QT PROLONGED 7 0.0002
702 LIMB DISCOMFORT 6 0.0002
703 SKIN ULCER 5 0.0002
704 LUNG INFECTION 3 0.0002
705 SWELLING 18 0.0002
706 ANHEDONIA 5 0.0002
707 ABDOMINAL PAIN UPPER 39 0.0002
708 NEUROPATHY PERIPHERAL 18 0.0002
709 INCONTINENCE 2 0.0002
710 JOINT DISLOCATION 2 0.0002
711 PNEUMOTHORAX 3 0.0002
712 COUGH 53 0.0002
713 MOOD SWINGS 6 0.0002
714 ABSCESS 3 0.0002
715 METABOLIC ACIDOSIS 6 0.0002
716 IMPAIRED WORK ABILITY 4 0.0002
717 PRODUCT DOSE OMISSION ISSUE 55 0.0002
718 MUSCLE TIGHTNESS 3 0.0002
719 THROAT TIGHTNESS 5 0.0002
720 ABDOMINAL DISCOMFORT 31 0.0002
721 BACK DISORDER 3 0.0002
722 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
723 ACUTE KIDNEY INJURY 28 0.0002
724 MANIA 3 0.0002
725 STOMATITIS 11 0.0002
726 RESPIRATORY DISTRESS 5 0.0002
727 DISCOMFORT 11 0.0002
728 DEHYDRATION 24 0.0002
729 MEDICATION ERROR 10 0.0002
730 TOOTH DISORDER 4 0.0002
731 SNEEZING 4 0.0002
732 HEMIPARESIS 3 0.0002
733 DISORIENTATION 7 0.0002
734 MYALGIA 30 0.0002
735 IMPAIRED DRIVING ABILITY 2 0.0002
736 DYSGEUSIA 13 0.0002
737 SEIZURE 20 0.0002
738 DECREASED APPETITE 40 0.0002
739 EYELID OEDEMA 2 0.0002
740 MUSCULOSKELETAL PAIN 9 0.0002
741 SPEECH DISORDER 9 0.0002
742 ASCITES 5 0.0002
743 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
744 LYMPHADENOPATHY 6 0.0002
745 HEAD DISCOMFORT 3 0.0002
746 PAIN 104 0.0002
747 GALLBLADDER DISORDER 3 0.0002
748 CHOLECYSTITIS 2 0.0002
749 DYSPNOEA 95 0.0002
750 PRODUCTIVE COUGH 8 0.0002
751 MUSCULAR WEAKNESS 19 0.0002
752 MYELOSUPPRESSION 6 0.0002
753 GASTROENTERITIS VIRAL 3 0.0002
754 CHEST DISCOMFORT 17 0.0002
755 HEPATITIS C 2 0.0002
756 NO ADVERSE EVENT 30 0.0002
757 LACRIMATION INCREASED 5 0.0002
758 INTERSTITIAL LUNG DISEASE 8 0.0002
759 DEATH 142 0.0002
760 BONE DISORDER 3 0.0002
761 PANIC ATTACK 6 0.0002
762 DIZZINESS 82 0.0002
763 ENCEPHALOPATHY 4 0.0002
764 FEELING ABNORMAL 39 0.0002
765 BLOOD GLUCOSE ABNORMAL 3 0.0002
766 CONJUNCTIVITIS 3 0.0002
767 VOMITING 76 0.0002
768 GENERALISED OEDEMA 2 0.0002
769 INSOMNIA 43 0.0002
770 EYE SWELLING 6 0.0002
771 MYOCARDIAL INFARCTION 28 0.0002
772 DRY MOUTH 13 0.0002
773 HYPOCALCAEMIA 3 0.0002
774 ACNE 12 0.0002
775 DEPRESSION 36 0.0002
776 ABDOMINAL PAIN LOWER 4 0.0002
777 DYSPHAGIA 15 0.0002
778 MUSCLE SPASMS 29 0.0002
779 INFLUENZA LIKE ILLNESS 13 0.0002
780 GASTRIC ULCER 3 0.0002
781 INJECTION SITE IRRITATION 2 0.0002
782 PULMONARY FIBROSIS 3 0.0002
783 ARTHRALGIA 65 0.0002
784 COMPLETED SUICIDE 13 0.0002
785 DRUG RESISTANCE 4 0.0002
786 RHINORRHOEA 10 0.0002
787 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 11 0.0002
788 HIATUS HERNIA 2 0.0002
789 CHOKING 3 0.0002
790 VISUAL IMPAIRMENT 19 0.0002
791 DEAFNESS 4 0.0002
792 EYE DISORDER 5 0.0002
793 NASOPHARYNGITIS 28 0.0002
794 STAPHYLOCOCCAL INFECTION 5 0.0002
795 BLOOD CHOLESTEROL INCREASED 7 0.0002
796 FUNGAL INFECTION 5 0.0001
797 SKIN DISORDER 5 0.0001
798 ABORTION SPONTANEOUS 6 0.0001
799 IRRITABILITY 9 0.0001
800 HAIR TEXTURE ABNORMAL 2 0.0001
801 CARDIAC FAILURE CONGESTIVE 12 0.0001
802 CEREBROVASCULAR ACCIDENT 25 0.0001
803 DIARRHOEA 95 0.0001
804 BODY TEMPERATURE INCREASED 3 0.0001
805 HYPOAESTHESIA 22 0.0001
806 OSTEOPOROSIS 6 0.0001
807 CORONARY ARTERY OCCLUSION 2 0.0001
808 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7 0.0001
809 APPLICATION SITE RASH 2 0.0001
810 CARDIO-RESPIRATORY ARREST 6 0.0001
811 WITHDRAWAL SYNDROME 6 0.0001
812 CARPAL TUNNEL SYNDROME 2 0.0001
813 MOUTH ULCERATION 3 0.0001
814 HYPONATRAEMIA 8 0.0001
815 OSTEOARTHRITIS 6 0.0001
816 PAIN IN JAW 4 0.0001
817 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
818 RETCHING 3 0.0001
819 LIVER FUNCTION TEST INCREASED 3 0.0001
820 RECTAL HAEMORRHAGE 6 0.0001
821 CARDIOGENIC SHOCK 2 0.0001
822 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
823 MENTAL DISORDER 6 0.0001
824 PRODUCT DOSE OMISSION 9 0.0001
825 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
826 NEEDLE ISSUE 4 0.0001
827 APATHY 2 0.0001
828 GASTROENTERITIS 2 0.0001
829 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
830 THERAPY CESSATION 7 0.0001
831 MELAENA 3 0.0001
832 DYSURIA 5 0.0001
833 INFLAMMATION 7 0.0001
834 RENAL INJURY 4 0.0001
835 SOMNOLENCE 27 0.0001
836 PULMONARY OEDEMA 6 0.0001
837 HYPERHIDROSIS 17 0.0001
838 ERYTHEMA 27 0.0001
839 SHOCK 3 0.0001
840 EMOTIONAL DISORDER 4 0.0001
841 ANKLE FRACTURE 2 0.0001
842 RASH PRURITIC 7 0.0001
843 RASH 56 0.0001
844 CONDITION AGGRAVATED 39 0.0001
845 CARDIAC DISORDER 12 0.0001
846 PALPITATIONS 15 0.0001
847 MALIGNANT NEOPLASM PROGRESSION 13 0.0001
848 COMA 6 0.0001
849 PRURITUS 48 0.0001
850 CARDIAC FAILURE 10 0.0001
851 HIP FRACTURE 4 0.0001
852 VISION BLURRED 17 0.0001
853 CONFUSIONAL STATE 20 0.0001
854 MEMORY IMPAIRMENT 17 0.0001
855 HOSPITALISATION 19 0.0001
856 CEREBRAL INFARCTION 3 0.0001
857 BLINDNESS 5 0.0001
858 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
859 DRUG LEVEL INCREASED 2 0.0001
860 PNEUMONIA ASPIRATION 3 0.0001
861 NEOPLASM MALIGNANT 8 0.0001
862 SURGERY 7 0.0001
863 UNEVALUABLE EVENT 9 0.0001
864 CARDIOVASCULAR DISORDER 3 0.0001
865 WHEEZING 7 0.0001
866 DRUG EXPOSURE DURING PREGNANCY 4 0.0001
867 INJECTION SITE SWELLING 9 0.0001
868 HYPOPHAGIA 3 0.0001
869 ANXIETY 33 0.0001
870 NIGHTMARE 4 0.0001
871 MUCOSAL INFLAMMATION 3 0.0001
872 ARTHRITIS 9 0.0001
873 RASH MACULAR 4 0.0001
874 JOINT STIFFNESS 3 0.0001
875 MUSCULOSKELETAL STIFFNESS 10 0.0001
876 BURNING SENSATION 8 0.0001
877 HEART RATE DECREASED 4 0.0001
878 HYPOXIA 4 0.0001
879 SLEEP DISORDER 8 0.0001
880 DRUG ERUPTION 2 0.0001
881 INJECTION SITE BRUISING 9 0.0001
882 EXPOSURE DURING PREGNANCY 7 0.0001
883 TACHYCARDIA 10 0.0001
884 PAIN OF SKIN 3 0.0001
885 DRUG EFFECT DECREASED 6 0.0001
886 PNEUMONITIS 3 0.0001
887 DRUG EFFECT INCOMPLETE 4 0.0001
888 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
889 CARDIAC ARREST 9 0.0001
890 RESPIRATORY ARREST 3 0.0001
891 TINNITUS 5 0.0001
892 HYPOKALAEMIA 5 0.0001
893 DIVERTICULITIS 3 0.0001
894 URTICARIA 18 0.0001
895 NECK PAIN 6 0.0001
896 OXYGEN SATURATION DECREASED 6 0.0001
897 EYE PAIN 6 0.0001
898 DYSARTHRIA 4 0.0001
899 ASTHMA 12 0.0001
900 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
901 COLITIS 4 0.0001
902 OCULAR HYPERAEMIA 5 0.0001
903 INCORRECT DOSE ADMINISTERED 24 0.0001
904 INCREASED APPETITE 2 0.0001
905 GLAUCOMA 2 0.0001
906 HYPOGLYCAEMIA 5 0.0001
907 PLASMA CELL MYELOMA 4 0.0001
908 CHILLS 12 0.0001
909 KIDNEY INFECTION 2 0.0001
910 DYSPEPSIA 10 0.0001
911 BLOOD GLUCOSE INCREASED 19 0.0001
912 ADVERSE DRUG REACTION 9 0.0001
913 HYPOTENSION 20 0.0001
914 APHASIA 3 0.0001
915 EMOTIONAL DISTRESS 12 0.0001
916 FEMUR FRACTURE 3 0.0001
917 ALOPECIA 19 0.0001
918 TREMOR 16 0.0001
919 POLLAKIURIA 4 0.0001
920 DERMATITIS 2 0.0001
921 KNEE ARTHROPLASTY 2 0.0001
922 BRADYCARDIA 5 0.0001
923 MOVEMENT DISORDER 3 0.0001
924 HYPOACUSIS 4 0.0001
925 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
926 INTENTIONAL PRODUCT MISUSE 8 0.0001
927 IMPAIRED HEALING 3 0.0001
928 HEART RATE INCREASED 9 0.0001
929 URINARY RETENTION 3 0.0001
930 GLOSSODYNIA 2 0.0001
931 THROAT IRRITATION 4 0.0001
932 ANGER 3 0.0001
933 HEART RATE IRREGULAR 2 0.0001
934 APPLICATION SITE PRURITUS 2 0.0001
935 BLOOD GLUCOSE DECREASED 4 0.0001
936 HEPATIC CANCER 2 0.0001
937 C-REACTIVE PROTEIN INCREASED 3 0.0001
938 VERTIGO 5 0.0001
939 FEELING HOT 5 0.0001
940 INJECTION SITE URTICARIA 2 0.0001
941 ABASIA 2 0.0001
942 INJECTION SITE ERYTHEMA 10 0.0001
943 LEUKOPENIA 4 0.0001
944 GASTROINTESTINAL DISORDER 7 0.0001
945 ANAPHYLACTIC SHOCK 2 0.0001
946 SUICIDAL IDEATION 7 0.0001
947 APPLICATION SITE ERYTHEMA 2 0.0001
948 PARAESTHESIA 12 0.0001
949 BREAST CANCER 7 0.0001
950 BREAST CANCER FEMALE 2 0.0001
951 INJECTION SITE PRURITUS 5 0.0001
952 ABNORMAL DREAMS 2 0.0001
953 FEELING COLD 2 0.0001
954 DEMENTIA 2 0.0001
955 SKIN EXFOLIATION 6 0.0001
956 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
957 FLATULENCE 4 0.0001
958 RHEUMATOID ARTHRITIS 8 0.0001
959 CONVULSION 4 0.0001
960 DEVICE DISLOCATION 3 0.0001
961 FLUSHING 7 0.0001
962 DRY SKIN 9 0.0001
963 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
964 INJECTION SITE RASH 2 0.0001
965 ARRHYTHMIA 3 0.0001
966 RASH ERYTHEMATOUS 3 0.0001
967 INJECTION SITE HAEMORRHAGE 5 0.0001
968 INJECTION SITE PAIN 19 0.0001
969 LACTIC ACIDOSIS 2 0.0001
970 FOETAL EXPOSURE DURING PREGNANCY 5 0.0001
971 DRUG DOSE OMISSION 10 0.0001
972 GAIT INABILITY 2 0.0001
973 GASTRIC DISORDER 2 0.0001
974 ECZEMA 3 0.0001
975 UNDERDOSE 4 0.0001
976 ADVERSE EVENT 5 0.0001
977 HALLUCINATION 4 0.0001
978 HOT FLUSH 4 0.0001
979 ABNORMAL BEHAVIOUR 2 0.0001
980 DRUG ABUSE 4 0.0000
981 DRUG WITHDRAWAL SYNDROME 4 0.0000
982 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
983 COLITIS ULCERATIVE 2 0.0000
984 INJECTION SITE REACTION 3 0.0000
985 THERAPY INTERRUPTED 3 0.0000
986 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 8 0.0000
987 PRODUCT QUALITY ISSUE 5 0.0000
988 TOXICITY TO VARIOUS AGENTS 6 0.0000
989 EYE IRRITATION 2 0.0000
990 PRODUCT STORAGE ERROR 3 0.0000
991 OVERDOSE 6 0.0000